Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
56.04
-0.12 (-0.21%)
At close: Mar 31, 2025, 4:00 PM
58.99
+2.95 (5.26%)
Pre-market: Apr 1, 2025, 4:59 AM EDT

Utah Medical Products Market Cap

Utah Medical Products has a market cap or net worth of $183.91 million as of April 1, 2025. Its market cap has decreased by -27.85% in one year.

Market Cap
183.91M
Enterprise Value
101.27M
1-Year Change
-27.85%
Ranking
Category
Stock Price
$56.04

Market Cap Chart

Since March 8, 1999, Utah Medical Products's market cap has increased from $49.30M to $183.91M, an increase of 273.05%. That is a compound annual growth rate of 5.18%.

History

DateMarket Cap% Change
Mar 28, 2025184.30M-11.61%
Dec 31, 2024208.50M-31.80%
Dec 29, 2023305.70M-16.18%
Dec 30, 2022364.70M-0.11%
Dec 31, 2021365.10M18.96%
Dec 31, 2020306.90M-23.56%
Dec 31, 2019401.50M29.43%
Dec 31, 2018310.20M2.41%
Dec 29, 2017302.90M10.71%
Dec 30, 2016273.60M24.65%
Dec 31, 2015219.50M-2.36%
Dec 31, 2014224.80M5.15%
Dec 31, 2013213.80M60.99%
Dec 31, 2012132.80M35.10%
Dec 30, 201198.30M1.13%
Dec 31, 201097.20M-8.13%
Dec 31, 2009105.80M25.95%
Dec 31, 200884.00M-27.84%
Dec 31, 2007116.40M-10.67%
Dec 29, 2006130.30M5.59%
Dec 30, 2005123.40M33.55%
Dec 31, 200492.40M-23.38%
Dec 31, 2003120.60M28.30%
Dec 31, 200294.00M37.43%
Dec 31, 200168.40M81.43%
View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings